biology

Verve PCSK9-inhibitor gene therapy

Verve PCSK9-inhibitor gene therapy is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Verve PCSK9-inhibitor gene therapy rather than just read about it. In short: VERVE-101 and VERVE-102 are an experimental gene therapy developed by Verve Therapeutics that targets the PCSK9 gene and is intended to reduce blood cholesterol levels. It works on the same protein as the cholesterol-lowering drugs known as PCSK9 inhibitors but, unlike them, is permanent.

Key takeaways

Verve PCSK9-inhibitor gene therapy belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Verve PCSK9-inhibitor gene therapy to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Verve PCSK9-inhibitor gene therapy from memory before moving on to harder problems.

Reference excerpt

VERVE-101 and VERVE-102 are an experimental gene therapy developed by Verve Therapeutics that targets the PCSK9 gene and is intended to reduce blood cholesterol levels. It works on the same protein as the cholesterol-lowering drugs known as PCSK9 inhibitors but, unlike them, is permanent. It works via base editing, a form of CRISPR gene editing. It is one of the first gene therapies that could be beneficial to a broad segment of the population, in contrast to earlier gene therapies that were developed to treat a rare genetic disorder. Both treatments use the same RNA gene editing technology, but they use a different lipid nanoparticle delivery vehicle.

Lilly Inc. Acquisition of Verve Therapeutics Lilly Inc.'s acquisition of Verve Therapeutics, Inc. was announced as a major biotechnology transaction in the gene-editing and cardiovascular therapeutics sector on June 17, 2025. Under the terms of the agreement, Lilly Inc. acquired 100% of Verve Therapeutics' equity. The acquisition is widely viewed as a strategic move to accelerate Lilly’s expansion into in vivo gene-editing therapies.

Research Verve Therapeutics voluntarily paused the Phase I Heart-1 trial of VERVE-101 after one out of six patients developed a transient Grade 3 drug-induced elevations of alanine aminotransferase and Grade 3 thrombocytopenia. In May 2026, the results of the Phase I Heart-2 trial were published in the New England Journal of Medicine. A total of 35 subjects with familial hypercholesterolemia or premature atherosclerosis received one intravenous infusion of VERVE-102 at one of six doses in an open-label, single-ascending-dose study and had at least 28 days of follow-up. Circulating PCSK9 protein and LDL cholesterol were reduced in a dose-dependent fashion, with mean LDL-C reduced by 62% (78 mg/dL) at the highest dose. The effect appeared to persist for at least 1 year of followup.

References

Worked examples

Example 1 — a first encounter with Verve PCSK9-inhibitor gene therapy

Start with the simplest possible case. Write down what Verve PCSK9-inhibitor gene therapy claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Verve PCSK9-inhibitor gene therapy before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Verve PCSK9-inhibitor gene therapy ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Verve PCSK9-inhibitor gene therapy

In research: Verve PCSK9-inhibitor gene therapy appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Verve PCSK9-inhibitor gene therapy in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Verve PCSK9-inhibitor gene therapy is common in secondary-school and first-year university syllabi. It links to neighbouring topics Experimental gene therapies, PCSK9 inhibitors, so understanding it makes those chapters shorter.
In everyday life: Look for Verve PCSK9-inhibitor gene therapy outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Verve PCSK9-inhibitor gene therapy” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Verve PCSK9-inhibitor gene therapy in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Verve PCSK9-inhibitor gene therapy means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Verve PCSK9-inhibitor gene therapy out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Verve PCSK9-inhibitor gene therapy in simple terms?

Why does Verve PCSK9-inhibitor gene therapy matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Verve PCSK9-inhibitor gene therapy?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Verve PCSK9-inhibitor gene therapy.